recent advanc phencyclidin model schizophrenia object phencyclidin pcp angel dust psychotomimet state schizophrenia amphetamine-induc psychosi pcp-induc psychosi posit hallucin paranoia neg emot withdraw motor retard schizophren symptom pcp-induc psychosi formal thought disord neuropsycholog deficit schizophrenia purpos present paper recent advanc studi molecular mechan pcp action implic understand schizophren pathophysiolog method twenty-f paper clinic dose serum csf level pcp psychotomimet effect dose rang pcp-induc effect dose rang pcp specif molecular target affect neurotransmiss result pcp-induc psychotomimet effect submicromolar serum concentr pcp concentr pcp specif bind site pcp receptor n-methyl-d-aspart nmda excitatori amino acid receptor occup receptor pcp induc noncompetit inhibit nmda receptor-medi neurotransmiss other nmda antagonist dissoci anesthet ketamin pcp-like neurobehavior effect proport potenc pcp receptor nmda receptor inhibit conclus find endogen dysfunct nmda receptor-medi neurotransmiss pathogenesi schizophrenia rel implic pcp amphetamin model schizophrenia relationship diagnosi etiolog schizophrenia 